Showing results (151-160 of 318) with videos related to

Sort By:
Pageof 32
European Journal of Public Health|January 15, 2024
Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech RepublicOndřej Ngo, Renata Chloupková, David Cibula, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 29, 2010
Steroid metabolome in fetal and maternal body fluids in human late pregnancyMartin Hill, Antonín Pařízek, David Cibula, et al.
Epigenomics|August 12, 2014
DNA methylation markers for early detection of women's cancer: promise and challengesTimo Wittenberger, Sara Sleigh, Daniel Reisel, et al.
Gynecologic Oncology|October 24, 2018
Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literatureDavid Cibula, Nadeem R Abu-Rustum, Daniela Fischerova, et al.
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
International Journal of Cancer|September 3, 2022
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancersLena Schreiberhuber, Chiara Herzog, Charlotte D Vavourakis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 7, 2022
Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO)Nicolò Bizzarri, Andrei Pletnev, Zoia Razumova, et al.
The Lancet. Oncology|July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control studyNuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 5, 2021
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)Lucia Musacchio, Vanda Salutari, Sandro Pignata, et al.
Annals of Surgical Oncology|October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluationChristina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.
Pageof 32